Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

Figure 1

The distribution of hepatic steatosis was categorized into four types in this study. (a) In the S0 group, less than 5% of hepatocytes were affected by steatosis (HE staining, ×200). (b) In the S1 group, 5–33% of hepatocytes were affected by steatosis (HE staining, ×200). (c) In the S2 group, 34–66% of hepatocytes were affected by steatosis (HE staining, ×200). (d) In the S3 group, more than 66% of hepatocytes were affected by steatosis (HE staining, ×200).

(a)

(b)

(c)

(d)